Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.

doi:10.1179/joc.1997.9.1.9

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.

Journal of chemotherapy (Florence, Italy) - 1 Feb 1997

Barry A L, Fuchs P C

Abstract excerpt

Grepafloxacin (OPC-17116) and three other fluoroquinolones were tested against 461 bacterial isolates representing 44 species. Grepafloxacin was superior to ciprofloxacin, ofloxacin and fleroxacin in its activity against the Gram-positive cocci, including staphylococci, pneumococci and hemolytic...

Topics

Anti-Infective Agents
Bacteria, Anaerobic
Ciprofloxacin
Drug Evaluation, Preclinical
Drug Resistance, Microbial
Enterobacteriaceae
Fleroxacin
Fluoroquinolones
Gram-Negative Bacteria
Gram-Positive Bacteria
Microbial Sensitivity Tests
Mutation
Ofloxacin
Piperazines
Quinolones

Source

Open in PubMed

Identifiers

PMID: 9106012
DOI: 10.1179/joc.1997.9.1.9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9106012-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics